Press Releases

NBTS Urges Congress to Keep Brain Tumor Research and Treatment Development Moving Forward David Arons, JD, president and chief executive officer of the National Brain Tumor Society, today released the following statement about averting a potential government shutdown at the end of the Fiscal Year on Friday, September 29, 2023: For thousands of Americans currently living with a brain tumor, the National Institutes of Health (NIH), through its […] September 26, 2023

New National Brain Tumor Society Program Highlighted by White House Cancer Moonshot Today, the White House Cancer Moonshot announced several important and novel initiatives to advance progress towards ending cancer as we know it. Highlighted in this announcement was NBTS’s commitment, made at the first White House Cancer Moonshot Brain Cancers Forum on Glioblastoma (GBM) & Diffuse Intrinsic Pontine Glioma (DIPG) during national Brain Tumor Awareness Month […] September 13, 2023

National Brain Tumor Society to Launch Campaigns Elevating the Necessity of Clinical Trials and Biomarker Testing Access, Guiding Patients to More Informed Treatment Options Joint initiatives aim to help patients and families navigate the era of precision medicine in cancer care National Brain Tumor Society (NBTS), a leader in brain tumor patient advocacy, research, information, and support, today announced the launch of two interrelated public health campaigns focused on patient awareness and access to advanced biomarker testing and clinical […] September 12, 2023

Leading Institute Joins Consortium on DNA Damage Response Treatments for Adults and Children with Brain Cancer Today, the National Brain Tumor Society (NBTS), in partnership with Yale Cancer Center, announced that Jann Sarkaria, MD, radiation oncologist, and co-leader of the Mayo Clinic Comprehensive Cancer Center Neuro-oncology program, is joining its DNA Damage Response Consortium. The consortium — which also comprises experts from St. Jude Children’s Research Hospital; Dana-Farber Cancer Institute; New […] August 31, 2023

Top Boston Hospitals Latest to Join Consortium Bringing Forward DNA Damage Response Treatments for Adults and Children with Brain Cancer Today, the National Brain Tumor Society (NBTS), in partnership with Yale Cancer Center, announced that experts from Dana-Farber Cancer Institute and Brigham & Women’s Hospital are joining its DNA Damage Response Consortium. The consortium — which also comprises teams from St. Jude Children’s Research Hospital; New York University Grossman School of Medicine (NYU); the University […] June 27, 2023